Illustration (
Illustration (

Govt Urges Public to Trust Benefits of Covid-19 Vaccine

English health and life (en)
Wahyu Dwi Anggoro • 20 October 2020 15:33
Jakarta: Spokesperson for the Covid-19 Task Force Reisa Brotoasmoro has called on the public to no longer have any reservation about the benefits of the covid-19 vaccine that the Government will provide.
“The vaccine has gone through a rigorous clinical trial supervised by government-owned authorities and international agencies in the health sector,” she was quoted by the Cabinet Secretariat's website as saying.
According to Reisa, the vaccine aims to create immunity in the human body to fight against diseases and also as a preventive effort against the virus.

Bagaimana tanggapan anda mengenai artikel ini?

“Vaccination is an effort to provide immunity into the body to fight the virus. This (vaccination) is expected to be effective in controlling the epidemic. It has even eradicated and eliminated epidemics and diseases in the world, such as smallpox and polio,” she was quoted as saying.
She went on to say the vaccine is complementary and will come gradually and will be injected according to the priority scale.
According to her, although the vaccine is already available, people must still follow health protocols of 3M (wearing face masks, maintaining distance, and washing hands.
She also explained that apart from the domestically-produced Red and White vaccine, Indonesia will also use vaccines produced by other countries through multilateral cooperation mechanisms.
The development and procurement of this vaccine, according to Reisa, is carried out by the Government based on the guidelines and recommendations of the World Health Organization (WHO), the Food and Drug Supervisory Agency (BPOM), experts as well as scholars and ulemas including the Indonesian Ulema Council (MUI).
Vice President Ma’ruf Amin, she added, has also stated that Islamic scholars are actively involved in the preparation of this vaccine.
She added that the BPOM has prepared an approval for the use of vaccine in an emergency called emergency use of authorization.
The BPOM also directly monitors the location of the Phase III clinical trial of the covid-19 vaccine by Indonesia’s Bio Farma in collaboration with China’s Sinovac located at Padjajaran University in the West Java capital of Bandung, she added.
It even conducts direct monitoring of vaccine development facilities owned by other countries, she said.
For the record, state-owned pharmacy company Bio Farma has been selected as one of the vaccine producers for the Coalition for Epidemic Preparedness Innovation (CEPI), which means that it is ready to produce covid-19 vaccine that are tested at the global level.

Ikuti media sosial dan dapatkan berbagai keuntungan

Dapatkan berita terbaru dari kami Ikuti langkah ini untuk mendapatkan notifikasi

unblock notif